Coldstream Capital Management Inc Abbott Laboratories Transaction History

Coldstream Capital Management Inc

  • $4.58 Billion
  • Q3 2024

A detailed history of Coldstream Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Coldstream Capital Management Inc holds 68,283 shares of ABT stock, worth $7.81 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
68,283
Previous 65,228 4.68%
Holding current value
$7.81 Million
Previous $6.78 Million 14.86%
% of portfolio
0.17%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$100.07 - $118.13 $305,713 - $360,887
3,055 Added 4.68%
68,283 $7.78 Million
Q2 2024

Aug 07, 2024
BUY
$100.73 - $112.44 $579,398 - $646,754
5,752 Added 9.67%
65,228 $6.78 Million
Q1 2024

May 13, 2024
BUY
$109.52 - $120.96 $113,681 - $125,556
1,038 Added 1.78%
59,476 $6.76 Million
Q4 2023

Feb 09, 2024
BUY
$90.19 - $110.4 $129,512 - $158,534
1,436 Added 2.52%
58,438 $6.43 Million
Q3 2023

Nov 02, 2023
SELL
$95.53 - $114.62 $75,373 - $90,435
-789 Reduced 1.37%
57,002 $5.52 Million
Q2 2023

Aug 03, 2023
SELL
$100.78 - $112.29 $112,772 - $125,652
-1,119 Reduced 1.9%
57,791 $6.3 Million
Q1 2023

May 15, 2023
SELL
$96.86 - $114.01 $227,911 - $268,265
-2,353 Reduced 3.84%
58,910 $5.97 Million
Q4 2022

Jan 10, 2023
BUY
$95.06 - $111.52 $472,448 - $554,254
4,970 Added 8.83%
61,263 $0
Q2 2022

Aug 08, 2022
BUY
$102.07 - $123.37 $1.08 Million - $1.3 Million
10,553 Added 23.07%
56,293 $6.12 Million
Q2 2022

Aug 08, 2022
SELL
$102.07 - $123.37 $656,310 - $793,269
-6,430 Reduced 12.33%
45,740 $4.97 Million
Q1 2022

May 11, 2022
SELL
$114.02 - $139.04 $137,394 - $167,543
-1,205 Reduced 2.26%
52,170 $6.18 Million
Q4 2021

Feb 11, 2022
BUY
$115.53 - $141.46 $1.63 Million - $2 Million
14,109 Added 35.93%
53,375 $7.51 Million
Q3 2021

Nov 12, 2021
SELL
$116.66 - $129.06 $142,675 - $157,840
-1,223 Reduced 3.02%
39,266 $4.27 Million
Q2 2021

Aug 16, 2021
SELL
$105.79 - $124.53 $20,946 - $24,656
-198 Reduced 0.49%
40,489 $4.69 Million
Q1 2021

Jun 16, 2021
BUY
$108.84 - $128.23 $62,256 - $73,347
572 Added 1.43%
40,687 $4.88 Million
Q4 2020

Feb 16, 2021
BUY
$105.0 - $114.42 $393,750 - $429,075
3,750 Added 10.31%
40,115 $4.39 Million
Q3 2020

Nov 16, 2020
BUY
$91.64 - $111.29 $73,220 - $88,920
799 Added 2.25%
36,365 $3.96 Million
Q2 2020

Aug 12, 2020
SELL
$76.57 - $98.0 $568,761 - $727,944
-7,428 Reduced 17.28%
35,566 $3.25 Million
Q1 2020

May 27, 2020
SELL
$62.82 - $91.86 $42,277 - $61,821
-673 Reduced 1.54%
42,994 $3.39 Million
Q4 2019

Feb 13, 2020
BUY
$78.51 - $87.4 $5,103 - $5,681
65 Added 0.15%
43,667 $3.79 Million
Q3 2019

Nov 15, 2019
SELL
$81.84 - $88.74 $220,476 - $239,065
-2,694 Reduced 5.82%
43,602 $3.65 Million
Q2 2019

Aug 15, 2019
SELL
$72.88 - $85.0 $21,135 - $24,650
-290 Reduced 0.62%
46,296 $3.89 Million
Q1 2019

May 10, 2019
SELL
$66.22 - $80.06 $133,963 - $161,961
-2,023 Reduced 4.16%
46,586 $3.72 Million
Q4 2018

Feb 26, 2019
BUY
$65.56 - $74.27 $2.59 Million - $2.94 Million
39,527 Added 435.22%
48,609 $3.52 Million
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $57,343 - $69,178
943 Added 11.59%
9,082 $666,000
Q2 2018

Aug 14, 2018
BUY
$57.57 - $63.54 $2,072 - $2,287
36 Added 0.44%
8,139 $497,000
Q1 2018

May 16, 2018
SELL
$56.27 - $63.62 $67,411 - $76,216
-1,198 Reduced 12.88%
8,103 $485,000
Q4 2017

Feb 14, 2018
BUY
$53.68 - $57.47 $16,962 - $18,160
316 Added 3.52%
9,301 $531,000
Q3 2017

Nov 15, 2017
BUY
$48.06 - $53.64 $168,258 - $187,793
3,501 Added 63.84%
8,985 $479,000
Q2 2017

Aug 15, 2017
BUY
N/A
5,484
5,484 $267,000

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email